Logo-apb
Adv Pharm Bull. 2023;13(2): 393-398. doi: 10.34172/apb.2023.038
PMID: 37342387        PMCID: PMC10278212

Research Article

The Impact of Single Nucleotide Polymorphisms on the Pharmacokinetics of Tacrolimus in Kidney Allograft Recipients of Northern-West, Iran

Elaheh Jabbari Hagh 1, Ali Mousavi 2, Seyyedeh Mina Hejazian 3 ORCID, Mehdi Haghi 4 ORCID, Samaneh Esfahanian 1, Elham Ahmadian 1 ORCID, Sepideh Zununi Vahed 1 * ORCID, Mohammadreza Ardalan 1 * ORCID

Cited by CrossRef: 1


1- Einollahi B, Nafar M, Javanbakht M, Alirezaei A, Azmandian J, Etminan A, Ardalan M, Etemadi J, Akbari R, Pourfarziani V, Hashemi S, Rahbar S, Shahidi S, Safa J, Khosroshahi H, Azar S, Ossareh S, Atapour A, Marghoob B, Nazemian F, Kafi H, Sabzvari A. Evaluation of efficacy and safety of generic tacrolimus (Suprotac®) compared to reference tacrolimus (Prograf®) in kidney transplantation: a phase IV study. Eur J Transl Myol. 2025; [Crossref]
2- Bouafia M, Smaali M, Zemmouchi S, Boumegoura A, Bellara S, Atoki A, Serrar R, Bouhedjar K, Messaoudi M, Abadi N, Belmahi M. The effect of CYP3A4, CYP3A5 and MDR1 (ABCB1) single nucleotide polymorphisms on the pharmacokinetics of cyclosporine in Algerian stable renal transplant recipients. Mol Biol Rep. 2025;52(1) [Crossref]
3- Staudinger J, Mahroke A, Patel G, Dattel C, Reddy S. Pregnane X Receptor Signaling Pathway and Vitamin K: Molecular Mechanisms and Clinical Relevance in Human Health. Cells. 2024;13(8):681 [Crossref]